Global PDE 4 Inhibitors Supply, Demand and Key Producers, 2023-2029
The global PDE 4 Inhibitors market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global PDE 4 Inhibitors production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for PDE 4 Inhibitors, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of PDE 4 Inhibitors that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global PDE 4 Inhibitors total production and demand, 2018-2029, (K Units)
Global PDE 4 Inhibitors total production value, 2018-2029, (USD Million)
Global PDE 4 Inhibitors production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global PDE 4 Inhibitors consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: PDE 4 Inhibitors domestic production, consumption, key domestic manufacturers and share
Global PDE 4 Inhibitors production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global PDE 4 Inhibitors production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global PDE 4 Inhibitors production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global PDE 4 Inhibitors market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer(Anacor), Arcutis Biotherapeutics, UNION Therapeutics, Innovent Biologics, Inc., Amgen, Ralington pharma LLP, Beijing Biolab Technology Co., Ltd., Nycomed and Forest, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PDE 4 Inhibitors market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global PDE 4 Inhibitors Market, By Region:
1. How big is the global PDE 4 Inhibitors market?
2. What is the demand of the global PDE 4 Inhibitors market?
3. What is the year over year growth of the global PDE 4 Inhibitors market?
4. What is the production and production value of the global PDE 4 Inhibitors market?
5. Who are the key producers in the global PDE 4 Inhibitors market?
6. What are the growth factors driving the market demand?
This report studies the global PDE 4 Inhibitors production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for PDE 4 Inhibitors, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of PDE 4 Inhibitors that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global PDE 4 Inhibitors total production and demand, 2018-2029, (K Units)
Global PDE 4 Inhibitors total production value, 2018-2029, (USD Million)
Global PDE 4 Inhibitors production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global PDE 4 Inhibitors consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: PDE 4 Inhibitors domestic production, consumption, key domestic manufacturers and share
Global PDE 4 Inhibitors production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global PDE 4 Inhibitors production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global PDE 4 Inhibitors production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global PDE 4 Inhibitors market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer(Anacor), Arcutis Biotherapeutics, UNION Therapeutics, Innovent Biologics, Inc., Amgen, Ralington pharma LLP, Beijing Biolab Technology Co., Ltd., Nycomed and Forest, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PDE 4 Inhibitors market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global PDE 4 Inhibitors Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Rolipram
- Tetomilast
- Cilomilast
- Criborole
- Apremilast
- Roflumilast
- Others
- Psoriasis
- Chronic Obstructive Pulmonary Disease (COPD)
- Asthma
- Ankylosing Spondylitis (AS)
- Inflammatory Bowel Disease (IBD)
- Atopic Dermatitis
- Rheumatoid Arthritis (RA)
- Systemic Lupus Erythematosus (SLE)
- Others
- Pfizer(Anacor)
- Arcutis Biotherapeutics
- UNION Therapeutics
- Innovent Biologics, Inc.
- Amgen
- Ralington pharma LLP
- Beijing Biolab Technology Co., Ltd.
- Nycomed
- Forest
- Bristol Myers
- GSK
1. How big is the global PDE 4 Inhibitors market?
2. What is the demand of the global PDE 4 Inhibitors market?
3. What is the year over year growth of the global PDE 4 Inhibitors market?
4. What is the production and production value of the global PDE 4 Inhibitors market?
5. Who are the key producers in the global PDE 4 Inhibitors market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 PDE 4 Inhibitors Introduction
1.2 World PDE 4 Inhibitors Supply & Forecast
1.2.1 World PDE 4 Inhibitors Production Value (2018 & 2022 & 2029)
1.2.2 World PDE 4 Inhibitors Production (2018-2029)
1.2.3 World PDE 4 Inhibitors Pricing Trends (2018-2029)
1.3 World PDE 4 Inhibitors Production by Region (Based on Production Site)
1.3.1 World PDE 4 Inhibitors Production Value by Region (2018-2029)
1.3.2 World PDE 4 Inhibitors Production by Region (2018-2029)
1.3.3 World PDE 4 Inhibitors Average Price by Region (2018-2029)
1.3.4 North America PDE 4 Inhibitors Production (2018-2029)
1.3.5 Europe PDE 4 Inhibitors Production (2018-2029)
1.3.6 China PDE 4 Inhibitors Production (2018-2029)
1.3.7 Japan PDE 4 Inhibitors Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 PDE 4 Inhibitors Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 PDE 4 Inhibitors Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World PDE 4 Inhibitors Demand (2018-2029)
2.2 World PDE 4 Inhibitors Consumption by Region
2.2.1 World PDE 4 Inhibitors Consumption by Region (2018-2023)
2.2.2 World PDE 4 Inhibitors Consumption Forecast by Region (2024-2029)
2.3 United States PDE 4 Inhibitors Consumption (2018-2029)
2.4 China PDE 4 Inhibitors Consumption (2018-2029)
2.5 Europe PDE 4 Inhibitors Consumption (2018-2029)
2.6 Japan PDE 4 Inhibitors Consumption (2018-2029)
2.7 South Korea PDE 4 Inhibitors Consumption (2018-2029)
2.8 ASEAN PDE 4 Inhibitors Consumption (2018-2029)
2.9 India PDE 4 Inhibitors Consumption (2018-2029)
3 WORLD PDE 4 INHIBITORS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World PDE 4 Inhibitors Production Value by Manufacturer (2018-2023)
3.2 World PDE 4 Inhibitors Production by Manufacturer (2018-2023)
3.3 World PDE 4 Inhibitors Average Price by Manufacturer (2018-2023)
3.4 PDE 4 Inhibitors Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global PDE 4 Inhibitors Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for PDE 4 Inhibitors in 2022
3.5.3 Global Concentration Ratios (CR8) for PDE 4 Inhibitors in 2022
3.6 PDE 4 Inhibitors Market: Overall Company Footprint Analysis
3.6.1 PDE 4 Inhibitors Market: Region Footprint
3.6.2 PDE 4 Inhibitors Market: Company Product Type Footprint
3.6.3 PDE 4 Inhibitors Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: PDE 4 Inhibitors Production Value Comparison
4.1.1 United States VS China: PDE 4 Inhibitors Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: PDE 4 Inhibitors Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: PDE 4 Inhibitors Production Comparison
4.2.1 United States VS China: PDE 4 Inhibitors Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: PDE 4 Inhibitors Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: PDE 4 Inhibitors Consumption Comparison
4.3.1 United States VS China: PDE 4 Inhibitors Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: PDE 4 Inhibitors Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based PDE 4 Inhibitors Manufacturers and Market Share, 2018-2023
4.4.1 United States Based PDE 4 Inhibitors Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers PDE 4 Inhibitors Production Value (2018-2023)
4.4.3 United States Based Manufacturers PDE 4 Inhibitors Production (2018-2023)
4.5 China Based PDE 4 Inhibitors Manufacturers and Market Share
4.5.1 China Based PDE 4 Inhibitors Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers PDE 4 Inhibitors Production Value (2018-2023)
4.5.3 China Based Manufacturers PDE 4 Inhibitors Production (2018-2023)
4.6 Rest of World Based PDE 4 Inhibitors Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based PDE 4 Inhibitors Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers PDE 4 Inhibitors Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers PDE 4 Inhibitors Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World PDE 4 Inhibitors Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Rolipram
5.2.2 Tetomilast
5.2.3 Cilomilast
5.2.4 Criborole
5.2.5 Apremilast
5.2.6 Roflumilast
5.2.7 Others
5.3 Market Segment by Type
5.3.1 World PDE 4 Inhibitors Production by Type (2018-2029)
5.3.2 World PDE 4 Inhibitors Production Value by Type (2018-2029)
5.3.3 World PDE 4 Inhibitors Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World PDE 4 Inhibitors Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Psoriasis
6.2.2 Chronic Obstructive Pulmonary Disease (COPD)
6.2.3 Asthma
6.2.4 Ankylosing Spondylitis (AS)
6.2.5 Inflammatory Bowel Disease (IBD)
6.2.6 Atopic Dermatitis
6.2.7 Rheumatoid Arthritis (RA)
6.2.8 Systemic Lupus Erythematosus (SLE)
6.2.9 Others
6.3 Market Segment by Application
6.3.1 World PDE 4 Inhibitors Production by Application (2018-2029)
6.3.2 World PDE 4 Inhibitors Production Value by Application (2018-2029)
6.3.3 World PDE 4 Inhibitors Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer(Anacor)
7.1.1 Pfizer(Anacor) Details
7.1.2 Pfizer(Anacor) Major Business
7.1.3 Pfizer(Anacor) PDE 4 Inhibitors Product and Services
7.1.4 Pfizer(Anacor) PDE 4 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer(Anacor) Recent Developments/Updates
7.1.6 Pfizer(Anacor) Competitive Strengths & Weaknesses
7.2 Arcutis Biotherapeutics
7.2.1 Arcutis Biotherapeutics Details
7.2.2 Arcutis Biotherapeutics Major Business
7.2.3 Arcutis Biotherapeutics PDE 4 Inhibitors Product and Services
7.2.4 Arcutis Biotherapeutics PDE 4 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Arcutis Biotherapeutics Recent Developments/Updates
7.2.6 Arcutis Biotherapeutics Competitive Strengths & Weaknesses
7.3 UNION Therapeutics
7.3.1 UNION Therapeutics Details
7.3.2 UNION Therapeutics Major Business
7.3.3 UNION Therapeutics PDE 4 Inhibitors Product and Services
7.3.4 UNION Therapeutics PDE 4 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 UNION Therapeutics Recent Developments/Updates
7.3.6 UNION Therapeutics Competitive Strengths & Weaknesses
7.4 Innovent Biologics, Inc.
7.4.1 Innovent Biologics, Inc. Details
7.4.2 Innovent Biologics, Inc. Major Business
7.4.3 Innovent Biologics, Inc. PDE 4 Inhibitors Product and Services
7.4.4 Innovent Biologics, Inc. PDE 4 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Innovent Biologics, Inc. Recent Developments/Updates
7.4.6 Innovent Biologics, Inc. Competitive Strengths & Weaknesses
7.5 Amgen
7.5.1 Amgen Details
7.5.2 Amgen Major Business
7.5.3 Amgen PDE 4 Inhibitors Product and Services
7.5.4 Amgen PDE 4 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Amgen Recent Developments/Updates
7.5.6 Amgen Competitive Strengths & Weaknesses
7.6 Ralington pharma LLP
7.6.1 Ralington pharma LLP Details
7.6.2 Ralington pharma LLP Major Business
7.6.3 Ralington pharma LLP PDE 4 Inhibitors Product and Services
7.6.4 Ralington pharma LLP PDE 4 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Ralington pharma LLP Recent Developments/Updates
7.6.6 Ralington pharma LLP Competitive Strengths & Weaknesses
7.7 Beijing Biolab Technology Co., Ltd.
7.7.1 Beijing Biolab Technology Co., Ltd. Details
7.7.2 Beijing Biolab Technology Co., Ltd. Major Business
7.7.3 Beijing Biolab Technology Co., Ltd. PDE 4 Inhibitors Product and Services
7.7.4 Beijing Biolab Technology Co., Ltd. PDE 4 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Beijing Biolab Technology Co., Ltd. Recent Developments/Updates
7.7.6 Beijing Biolab Technology Co., Ltd. Competitive Strengths & Weaknesses
7.8 Nycomed
7.8.1 Nycomed Details
7.8.2 Nycomed Major Business
7.8.3 Nycomed PDE 4 Inhibitors Product and Services
7.8.4 Nycomed PDE 4 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Nycomed Recent Developments/Updates
7.8.6 Nycomed Competitive Strengths & Weaknesses
7.9 Forest
7.9.1 Forest Details
7.9.2 Forest Major Business
7.9.3 Forest PDE 4 Inhibitors Product and Services
7.9.4 Forest PDE 4 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Forest Recent Developments/Updates
7.9.6 Forest Competitive Strengths & Weaknesses
7.10 Bristol Myers
7.10.1 Bristol Myers Details
7.10.2 Bristol Myers Major Business
7.10.3 Bristol Myers PDE 4 Inhibitors Product and Services
7.10.4 Bristol Myers PDE 4 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Bristol Myers Recent Developments/Updates
7.10.6 Bristol Myers Competitive Strengths & Weaknesses
7.11 GSK
7.11.1 GSK Details
7.11.2 GSK Major Business
7.11.3 GSK PDE 4 Inhibitors Product and Services
7.11.4 GSK PDE 4 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 GSK Recent Developments/Updates
7.11.6 GSK Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 PDE 4 Inhibitors Industry Chain
8.2 PDE 4 Inhibitors Upstream Analysis
8.2.1 PDE 4 Inhibitors Core Raw Materials
8.2.2 Main Manufacturers of PDE 4 Inhibitors Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 PDE 4 Inhibitors Production Mode
8.6 PDE 4 Inhibitors Procurement Model
8.7 PDE 4 Inhibitors Industry Sales Model and Sales Channels
8.7.1 PDE 4 Inhibitors Sales Model
8.7.2 PDE 4 Inhibitors Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 PDE 4 Inhibitors Introduction
1.2 World PDE 4 Inhibitors Supply & Forecast
1.2.1 World PDE 4 Inhibitors Production Value (2018 & 2022 & 2029)
1.2.2 World PDE 4 Inhibitors Production (2018-2029)
1.2.3 World PDE 4 Inhibitors Pricing Trends (2018-2029)
1.3 World PDE 4 Inhibitors Production by Region (Based on Production Site)
1.3.1 World PDE 4 Inhibitors Production Value by Region (2018-2029)
1.3.2 World PDE 4 Inhibitors Production by Region (2018-2029)
1.3.3 World PDE 4 Inhibitors Average Price by Region (2018-2029)
1.3.4 North America PDE 4 Inhibitors Production (2018-2029)
1.3.5 Europe PDE 4 Inhibitors Production (2018-2029)
1.3.6 China PDE 4 Inhibitors Production (2018-2029)
1.3.7 Japan PDE 4 Inhibitors Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 PDE 4 Inhibitors Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 PDE 4 Inhibitors Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World PDE 4 Inhibitors Demand (2018-2029)
2.2 World PDE 4 Inhibitors Consumption by Region
2.2.1 World PDE 4 Inhibitors Consumption by Region (2018-2023)
2.2.2 World PDE 4 Inhibitors Consumption Forecast by Region (2024-2029)
2.3 United States PDE 4 Inhibitors Consumption (2018-2029)
2.4 China PDE 4 Inhibitors Consumption (2018-2029)
2.5 Europe PDE 4 Inhibitors Consumption (2018-2029)
2.6 Japan PDE 4 Inhibitors Consumption (2018-2029)
2.7 South Korea PDE 4 Inhibitors Consumption (2018-2029)
2.8 ASEAN PDE 4 Inhibitors Consumption (2018-2029)
2.9 India PDE 4 Inhibitors Consumption (2018-2029)
3 WORLD PDE 4 INHIBITORS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World PDE 4 Inhibitors Production Value by Manufacturer (2018-2023)
3.2 World PDE 4 Inhibitors Production by Manufacturer (2018-2023)
3.3 World PDE 4 Inhibitors Average Price by Manufacturer (2018-2023)
3.4 PDE 4 Inhibitors Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global PDE 4 Inhibitors Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for PDE 4 Inhibitors in 2022
3.5.3 Global Concentration Ratios (CR8) for PDE 4 Inhibitors in 2022
3.6 PDE 4 Inhibitors Market: Overall Company Footprint Analysis
3.6.1 PDE 4 Inhibitors Market: Region Footprint
3.6.2 PDE 4 Inhibitors Market: Company Product Type Footprint
3.6.3 PDE 4 Inhibitors Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: PDE 4 Inhibitors Production Value Comparison
4.1.1 United States VS China: PDE 4 Inhibitors Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: PDE 4 Inhibitors Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: PDE 4 Inhibitors Production Comparison
4.2.1 United States VS China: PDE 4 Inhibitors Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: PDE 4 Inhibitors Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: PDE 4 Inhibitors Consumption Comparison
4.3.1 United States VS China: PDE 4 Inhibitors Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: PDE 4 Inhibitors Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based PDE 4 Inhibitors Manufacturers and Market Share, 2018-2023
4.4.1 United States Based PDE 4 Inhibitors Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers PDE 4 Inhibitors Production Value (2018-2023)
4.4.3 United States Based Manufacturers PDE 4 Inhibitors Production (2018-2023)
4.5 China Based PDE 4 Inhibitors Manufacturers and Market Share
4.5.1 China Based PDE 4 Inhibitors Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers PDE 4 Inhibitors Production Value (2018-2023)
4.5.3 China Based Manufacturers PDE 4 Inhibitors Production (2018-2023)
4.6 Rest of World Based PDE 4 Inhibitors Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based PDE 4 Inhibitors Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers PDE 4 Inhibitors Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers PDE 4 Inhibitors Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World PDE 4 Inhibitors Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Rolipram
5.2.2 Tetomilast
5.2.3 Cilomilast
5.2.4 Criborole
5.2.5 Apremilast
5.2.6 Roflumilast
5.2.7 Others
5.3 Market Segment by Type
5.3.1 World PDE 4 Inhibitors Production by Type (2018-2029)
5.3.2 World PDE 4 Inhibitors Production Value by Type (2018-2029)
5.3.3 World PDE 4 Inhibitors Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World PDE 4 Inhibitors Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Psoriasis
6.2.2 Chronic Obstructive Pulmonary Disease (COPD)
6.2.3 Asthma
6.2.4 Ankylosing Spondylitis (AS)
6.2.5 Inflammatory Bowel Disease (IBD)
6.2.6 Atopic Dermatitis
6.2.7 Rheumatoid Arthritis (RA)
6.2.8 Systemic Lupus Erythematosus (SLE)
6.2.9 Others
6.3 Market Segment by Application
6.3.1 World PDE 4 Inhibitors Production by Application (2018-2029)
6.3.2 World PDE 4 Inhibitors Production Value by Application (2018-2029)
6.3.3 World PDE 4 Inhibitors Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer(Anacor)
7.1.1 Pfizer(Anacor) Details
7.1.2 Pfizer(Anacor) Major Business
7.1.3 Pfizer(Anacor) PDE 4 Inhibitors Product and Services
7.1.4 Pfizer(Anacor) PDE 4 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer(Anacor) Recent Developments/Updates
7.1.6 Pfizer(Anacor) Competitive Strengths & Weaknesses
7.2 Arcutis Biotherapeutics
7.2.1 Arcutis Biotherapeutics Details
7.2.2 Arcutis Biotherapeutics Major Business
7.2.3 Arcutis Biotherapeutics PDE 4 Inhibitors Product and Services
7.2.4 Arcutis Biotherapeutics PDE 4 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Arcutis Biotherapeutics Recent Developments/Updates
7.2.6 Arcutis Biotherapeutics Competitive Strengths & Weaknesses
7.3 UNION Therapeutics
7.3.1 UNION Therapeutics Details
7.3.2 UNION Therapeutics Major Business
7.3.3 UNION Therapeutics PDE 4 Inhibitors Product and Services
7.3.4 UNION Therapeutics PDE 4 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 UNION Therapeutics Recent Developments/Updates
7.3.6 UNION Therapeutics Competitive Strengths & Weaknesses
7.4 Innovent Biologics, Inc.
7.4.1 Innovent Biologics, Inc. Details
7.4.2 Innovent Biologics, Inc. Major Business
7.4.3 Innovent Biologics, Inc. PDE 4 Inhibitors Product and Services
7.4.4 Innovent Biologics, Inc. PDE 4 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Innovent Biologics, Inc. Recent Developments/Updates
7.4.6 Innovent Biologics, Inc. Competitive Strengths & Weaknesses
7.5 Amgen
7.5.1 Amgen Details
7.5.2 Amgen Major Business
7.5.3 Amgen PDE 4 Inhibitors Product and Services
7.5.4 Amgen PDE 4 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Amgen Recent Developments/Updates
7.5.6 Amgen Competitive Strengths & Weaknesses
7.6 Ralington pharma LLP
7.6.1 Ralington pharma LLP Details
7.6.2 Ralington pharma LLP Major Business
7.6.3 Ralington pharma LLP PDE 4 Inhibitors Product and Services
7.6.4 Ralington pharma LLP PDE 4 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Ralington pharma LLP Recent Developments/Updates
7.6.6 Ralington pharma LLP Competitive Strengths & Weaknesses
7.7 Beijing Biolab Technology Co., Ltd.
7.7.1 Beijing Biolab Technology Co., Ltd. Details
7.7.2 Beijing Biolab Technology Co., Ltd. Major Business
7.7.3 Beijing Biolab Technology Co., Ltd. PDE 4 Inhibitors Product and Services
7.7.4 Beijing Biolab Technology Co., Ltd. PDE 4 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Beijing Biolab Technology Co., Ltd. Recent Developments/Updates
7.7.6 Beijing Biolab Technology Co., Ltd. Competitive Strengths & Weaknesses
7.8 Nycomed
7.8.1 Nycomed Details
7.8.2 Nycomed Major Business
7.8.3 Nycomed PDE 4 Inhibitors Product and Services
7.8.4 Nycomed PDE 4 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Nycomed Recent Developments/Updates
7.8.6 Nycomed Competitive Strengths & Weaknesses
7.9 Forest
7.9.1 Forest Details
7.9.2 Forest Major Business
7.9.3 Forest PDE 4 Inhibitors Product and Services
7.9.4 Forest PDE 4 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Forest Recent Developments/Updates
7.9.6 Forest Competitive Strengths & Weaknesses
7.10 Bristol Myers
7.10.1 Bristol Myers Details
7.10.2 Bristol Myers Major Business
7.10.3 Bristol Myers PDE 4 Inhibitors Product and Services
7.10.4 Bristol Myers PDE 4 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Bristol Myers Recent Developments/Updates
7.10.6 Bristol Myers Competitive Strengths & Weaknesses
7.11 GSK
7.11.1 GSK Details
7.11.2 GSK Major Business
7.11.3 GSK PDE 4 Inhibitors Product and Services
7.11.4 GSK PDE 4 Inhibitors Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 GSK Recent Developments/Updates
7.11.6 GSK Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 PDE 4 Inhibitors Industry Chain
8.2 PDE 4 Inhibitors Upstream Analysis
8.2.1 PDE 4 Inhibitors Core Raw Materials
8.2.2 Main Manufacturers of PDE 4 Inhibitors Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 PDE 4 Inhibitors Production Mode
8.6 PDE 4 Inhibitors Procurement Model
8.7 PDE 4 Inhibitors Industry Sales Model and Sales Channels
8.7.1 PDE 4 Inhibitors Sales Model
8.7.2 PDE 4 Inhibitors Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World PDE 4 Inhibitors Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World PDE 4 Inhibitors Production Value by Region (2018-2023) & (USD Million)
Table 3. World PDE 4 Inhibitors Production Value by Region (2024-2029) & (USD Million)
Table 4. World PDE 4 Inhibitors Production Value Market Share by Region (2018-2023)
Table 5. World PDE 4 Inhibitors Production Value Market Share by Region (2024-2029)
Table 6. World PDE 4 Inhibitors Production by Region (2018-2023) & (K Units)
Table 7. World PDE 4 Inhibitors Production by Region (2024-2029) & (K Units)
Table 8. World PDE 4 Inhibitors Production Market Share by Region (2018-2023)
Table 9. World PDE 4 Inhibitors Production Market Share by Region (2024-2029)
Table 10. World PDE 4 Inhibitors Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World PDE 4 Inhibitors Average Price by Region (2024-2029) & (US$/Unit)
Table 12. PDE 4 Inhibitors Major Market Trends
Table 13. World PDE 4 Inhibitors Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World PDE 4 Inhibitors Consumption by Region (2018-2023) & (K Units)
Table 15. World PDE 4 Inhibitors Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World PDE 4 Inhibitors Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key PDE 4 Inhibitors Producers in 2022
Table 18. World PDE 4 Inhibitors Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key PDE 4 Inhibitors Producers in 2022
Table 20. World PDE 4 Inhibitors Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global PDE 4 Inhibitors Company Evaluation Quadrant
Table 22. World PDE 4 Inhibitors Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and PDE 4 Inhibitors Production Site of Key Manufacturer
Table 24. PDE 4 Inhibitors Market: Company Product Type Footprint
Table 25. PDE 4 Inhibitors Market: Company Product Application Footprint
Table 26. PDE 4 Inhibitors Competitive Factors
Table 27. PDE 4 Inhibitors New Entrant and Capacity Expansion Plans
Table 28. PDE 4 Inhibitors Mergers & Acquisitions Activity
Table 29. United States VS China PDE 4 Inhibitors Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China PDE 4 Inhibitors Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China PDE 4 Inhibitors Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based PDE 4 Inhibitors Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers PDE 4 Inhibitors Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers PDE 4 Inhibitors Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers PDE 4 Inhibitors Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers PDE 4 Inhibitors Production Market Share (2018-2023)
Table 37. China Based PDE 4 Inhibitors Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers PDE 4 Inhibitors Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers PDE 4 Inhibitors Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers PDE 4 Inhibitors Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers PDE 4 Inhibitors Production Market Share (2018-2023)
Table 42. Rest of World Based PDE 4 Inhibitors Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers PDE 4 Inhibitors Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers PDE 4 Inhibitors Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers PDE 4 Inhibitors Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers PDE 4 Inhibitors Production Market Share (2018-2023)
Table 47. World PDE 4 Inhibitors Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World PDE 4 Inhibitors Production by Type (2018-2023) & (K Units)
Table 49. World PDE 4 Inhibitors Production by Type (2024-2029) & (K Units)
Table 50. World PDE 4 Inhibitors Production Value by Type (2018-2023) & (USD Million)
Table 51. World PDE 4 Inhibitors Production Value by Type (2024-2029) & (USD Million)
Table 52. World PDE 4 Inhibitors Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World PDE 4 Inhibitors Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World PDE 4 Inhibitors Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World PDE 4 Inhibitors Production by Application (2018-2023) & (K Units)
Table 56. World PDE 4 Inhibitors Production by Application (2024-2029) & (K Units)
Table 57. World PDE 4 Inhibitors Production Value by Application (2018-2023) & (USD Million)
Table 58. World PDE 4 Inhibitors Production Value by Application (2024-2029) & (USD Million)
Table 59. World PDE 4 Inhibitors Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World PDE 4 Inhibitors Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer(Anacor) Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer(Anacor) Major Business
Table 63. Pfizer(Anacor) PDE 4 Inhibitors Product and Services
Table 64. Pfizer(Anacor) PDE 4 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer(Anacor) Recent Developments/Updates
Table 66. Pfizer(Anacor) Competitive Strengths & Weaknesses
Table 67. Arcutis Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 68. Arcutis Biotherapeutics Major Business
Table 69. Arcutis Biotherapeutics PDE 4 Inhibitors Product and Services
Table 70. Arcutis Biotherapeutics PDE 4 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Arcutis Biotherapeutics Recent Developments/Updates
Table 72. Arcutis Biotherapeutics Competitive Strengths & Weaknesses
Table 73. UNION Therapeutics Basic Information, Manufacturing Base and Competitors
Table 74. UNION Therapeutics Major Business
Table 75. UNION Therapeutics PDE 4 Inhibitors Product and Services
Table 76. UNION Therapeutics PDE 4 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. UNION Therapeutics Recent Developments/Updates
Table 78. UNION Therapeutics Competitive Strengths & Weaknesses
Table 79. Innovent Biologics, Inc. Basic Information, Manufacturing Base and Competitors
Table 80. Innovent Biologics, Inc. Major Business
Table 81. Innovent Biologics, Inc. PDE 4 Inhibitors Product and Services
Table 82. Innovent Biologics, Inc. PDE 4 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Innovent Biologics, Inc. Recent Developments/Updates
Table 84. Innovent Biologics, Inc. Competitive Strengths & Weaknesses
Table 85. Amgen Basic Information, Manufacturing Base and Competitors
Table 86. Amgen Major Business
Table 87. Amgen PDE 4 Inhibitors Product and Services
Table 88. Amgen PDE 4 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Amgen Recent Developments/Updates
Table 90. Amgen Competitive Strengths & Weaknesses
Table 91. Ralington pharma LLP Basic Information, Manufacturing Base and Competitors
Table 92. Ralington pharma LLP Major Business
Table 93. Ralington pharma LLP PDE 4 Inhibitors Product and Services
Table 94. Ralington pharma LLP PDE 4 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Ralington pharma LLP Recent Developments/Updates
Table 96. Ralington pharma LLP Competitive Strengths & Weaknesses
Table 97. Beijing Biolab Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 98. Beijing Biolab Technology Co., Ltd. Major Business
Table 99. Beijing Biolab Technology Co., Ltd. PDE 4 Inhibitors Product and Services
Table 100. Beijing Biolab Technology Co., Ltd. PDE 4 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Beijing Biolab Technology Co., Ltd. Recent Developments/Updates
Table 102. Beijing Biolab Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 103. Nycomed Basic Information, Manufacturing Base and Competitors
Table 104. Nycomed Major Business
Table 105. Nycomed PDE 4 Inhibitors Product and Services
Table 106. Nycomed PDE 4 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Nycomed Recent Developments/Updates
Table 108. Nycomed Competitive Strengths & Weaknesses
Table 109. Forest Basic Information, Manufacturing Base and Competitors
Table 110. Forest Major Business
Table 111. Forest PDE 4 Inhibitors Product and Services
Table 112. Forest PDE 4 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Forest Recent Developments/Updates
Table 114. Forest Competitive Strengths & Weaknesses
Table 115. Bristol Myers Basic Information, Manufacturing Base and Competitors
Table 116. Bristol Myers Major Business
Table 117. Bristol Myers PDE 4 Inhibitors Product and Services
Table 118. Bristol Myers PDE 4 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Bristol Myers Recent Developments/Updates
Table 120. GSK Basic Information, Manufacturing Base and Competitors
Table 121. GSK Major Business
Table 122. GSK PDE 4 Inhibitors Product and Services
Table 123. GSK PDE 4 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Global Key Players of PDE 4 Inhibitors Upstream (Raw Materials)
Table 125. PDE 4 Inhibitors Typical Customers
Table 126. PDE 4 Inhibitors Typical Distributors
Table 1. World PDE 4 Inhibitors Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World PDE 4 Inhibitors Production Value by Region (2018-2023) & (USD Million)
Table 3. World PDE 4 Inhibitors Production Value by Region (2024-2029) & (USD Million)
Table 4. World PDE 4 Inhibitors Production Value Market Share by Region (2018-2023)
Table 5. World PDE 4 Inhibitors Production Value Market Share by Region (2024-2029)
Table 6. World PDE 4 Inhibitors Production by Region (2018-2023) & (K Units)
Table 7. World PDE 4 Inhibitors Production by Region (2024-2029) & (K Units)
Table 8. World PDE 4 Inhibitors Production Market Share by Region (2018-2023)
Table 9. World PDE 4 Inhibitors Production Market Share by Region (2024-2029)
Table 10. World PDE 4 Inhibitors Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World PDE 4 Inhibitors Average Price by Region (2024-2029) & (US$/Unit)
Table 12. PDE 4 Inhibitors Major Market Trends
Table 13. World PDE 4 Inhibitors Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World PDE 4 Inhibitors Consumption by Region (2018-2023) & (K Units)
Table 15. World PDE 4 Inhibitors Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World PDE 4 Inhibitors Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key PDE 4 Inhibitors Producers in 2022
Table 18. World PDE 4 Inhibitors Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key PDE 4 Inhibitors Producers in 2022
Table 20. World PDE 4 Inhibitors Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global PDE 4 Inhibitors Company Evaluation Quadrant
Table 22. World PDE 4 Inhibitors Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and PDE 4 Inhibitors Production Site of Key Manufacturer
Table 24. PDE 4 Inhibitors Market: Company Product Type Footprint
Table 25. PDE 4 Inhibitors Market: Company Product Application Footprint
Table 26. PDE 4 Inhibitors Competitive Factors
Table 27. PDE 4 Inhibitors New Entrant and Capacity Expansion Plans
Table 28. PDE 4 Inhibitors Mergers & Acquisitions Activity
Table 29. United States VS China PDE 4 Inhibitors Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China PDE 4 Inhibitors Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China PDE 4 Inhibitors Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based PDE 4 Inhibitors Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers PDE 4 Inhibitors Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers PDE 4 Inhibitors Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers PDE 4 Inhibitors Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers PDE 4 Inhibitors Production Market Share (2018-2023)
Table 37. China Based PDE 4 Inhibitors Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers PDE 4 Inhibitors Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers PDE 4 Inhibitors Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers PDE 4 Inhibitors Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers PDE 4 Inhibitors Production Market Share (2018-2023)
Table 42. Rest of World Based PDE 4 Inhibitors Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers PDE 4 Inhibitors Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers PDE 4 Inhibitors Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers PDE 4 Inhibitors Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers PDE 4 Inhibitors Production Market Share (2018-2023)
Table 47. World PDE 4 Inhibitors Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World PDE 4 Inhibitors Production by Type (2018-2023) & (K Units)
Table 49. World PDE 4 Inhibitors Production by Type (2024-2029) & (K Units)
Table 50. World PDE 4 Inhibitors Production Value by Type (2018-2023) & (USD Million)
Table 51. World PDE 4 Inhibitors Production Value by Type (2024-2029) & (USD Million)
Table 52. World PDE 4 Inhibitors Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World PDE 4 Inhibitors Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World PDE 4 Inhibitors Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World PDE 4 Inhibitors Production by Application (2018-2023) & (K Units)
Table 56. World PDE 4 Inhibitors Production by Application (2024-2029) & (K Units)
Table 57. World PDE 4 Inhibitors Production Value by Application (2018-2023) & (USD Million)
Table 58. World PDE 4 Inhibitors Production Value by Application (2024-2029) & (USD Million)
Table 59. World PDE 4 Inhibitors Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World PDE 4 Inhibitors Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer(Anacor) Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer(Anacor) Major Business
Table 63. Pfizer(Anacor) PDE 4 Inhibitors Product and Services
Table 64. Pfizer(Anacor) PDE 4 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer(Anacor) Recent Developments/Updates
Table 66. Pfizer(Anacor) Competitive Strengths & Weaknesses
Table 67. Arcutis Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 68. Arcutis Biotherapeutics Major Business
Table 69. Arcutis Biotherapeutics PDE 4 Inhibitors Product and Services
Table 70. Arcutis Biotherapeutics PDE 4 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Arcutis Biotherapeutics Recent Developments/Updates
Table 72. Arcutis Biotherapeutics Competitive Strengths & Weaknesses
Table 73. UNION Therapeutics Basic Information, Manufacturing Base and Competitors
Table 74. UNION Therapeutics Major Business
Table 75. UNION Therapeutics PDE 4 Inhibitors Product and Services
Table 76. UNION Therapeutics PDE 4 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. UNION Therapeutics Recent Developments/Updates
Table 78. UNION Therapeutics Competitive Strengths & Weaknesses
Table 79. Innovent Biologics, Inc. Basic Information, Manufacturing Base and Competitors
Table 80. Innovent Biologics, Inc. Major Business
Table 81. Innovent Biologics, Inc. PDE 4 Inhibitors Product and Services
Table 82. Innovent Biologics, Inc. PDE 4 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Innovent Biologics, Inc. Recent Developments/Updates
Table 84. Innovent Biologics, Inc. Competitive Strengths & Weaknesses
Table 85. Amgen Basic Information, Manufacturing Base and Competitors
Table 86. Amgen Major Business
Table 87. Amgen PDE 4 Inhibitors Product and Services
Table 88. Amgen PDE 4 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Amgen Recent Developments/Updates
Table 90. Amgen Competitive Strengths & Weaknesses
Table 91. Ralington pharma LLP Basic Information, Manufacturing Base and Competitors
Table 92. Ralington pharma LLP Major Business
Table 93. Ralington pharma LLP PDE 4 Inhibitors Product and Services
Table 94. Ralington pharma LLP PDE 4 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Ralington pharma LLP Recent Developments/Updates
Table 96. Ralington pharma LLP Competitive Strengths & Weaknesses
Table 97. Beijing Biolab Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 98. Beijing Biolab Technology Co., Ltd. Major Business
Table 99. Beijing Biolab Technology Co., Ltd. PDE 4 Inhibitors Product and Services
Table 100. Beijing Biolab Technology Co., Ltd. PDE 4 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Beijing Biolab Technology Co., Ltd. Recent Developments/Updates
Table 102. Beijing Biolab Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 103. Nycomed Basic Information, Manufacturing Base and Competitors
Table 104. Nycomed Major Business
Table 105. Nycomed PDE 4 Inhibitors Product and Services
Table 106. Nycomed PDE 4 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Nycomed Recent Developments/Updates
Table 108. Nycomed Competitive Strengths & Weaknesses
Table 109. Forest Basic Information, Manufacturing Base and Competitors
Table 110. Forest Major Business
Table 111. Forest PDE 4 Inhibitors Product and Services
Table 112. Forest PDE 4 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Forest Recent Developments/Updates
Table 114. Forest Competitive Strengths & Weaknesses
Table 115. Bristol Myers Basic Information, Manufacturing Base and Competitors
Table 116. Bristol Myers Major Business
Table 117. Bristol Myers PDE 4 Inhibitors Product and Services
Table 118. Bristol Myers PDE 4 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Bristol Myers Recent Developments/Updates
Table 120. GSK Basic Information, Manufacturing Base and Competitors
Table 121. GSK Major Business
Table 122. GSK PDE 4 Inhibitors Product and Services
Table 123. GSK PDE 4 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Global Key Players of PDE 4 Inhibitors Upstream (Raw Materials)
Table 125. PDE 4 Inhibitors Typical Customers
Table 126. PDE 4 Inhibitors Typical Distributors
LIST OF FIGURES
Figure 1. PDE 4 Inhibitors Picture
Figure 2. World PDE 4 Inhibitors Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World PDE 4 Inhibitors Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World PDE 4 Inhibitors Production (2018-2029) & (K Units)
Figure 5. World PDE 4 Inhibitors Average Price (2018-2029) & (US$/Unit)
Figure 6. World PDE 4 Inhibitors Production Value Market Share by Region (2018-2029)
Figure 7. World PDE 4 Inhibitors Production Market Share by Region (2018-2029)
Figure 8. North America PDE 4 Inhibitors Production (2018-2029) & (K Units)
Figure 9. Europe PDE 4 Inhibitors Production (2018-2029) & (K Units)
Figure 10. China PDE 4 Inhibitors Production (2018-2029) & (K Units)
Figure 11. Japan PDE 4 Inhibitors Production (2018-2029) & (K Units)
Figure 12. PDE 4 Inhibitors Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World PDE 4 Inhibitors Consumption (2018-2029) & (K Units)
Figure 15. World PDE 4 Inhibitors Consumption Market Share by Region (2018-2029)
Figure 16. United States PDE 4 Inhibitors Consumption (2018-2029) & (K Units)
Figure 17. China PDE 4 Inhibitors Consumption (2018-2029) & (K Units)
Figure 18. Europe PDE 4 Inhibitors Consumption (2018-2029) & (K Units)
Figure 19. Japan PDE 4 Inhibitors Consumption (2018-2029) & (K Units)
Figure 20. South Korea PDE 4 Inhibitors Consumption (2018-2029) & (K Units)
Figure 21. ASEAN PDE 4 Inhibitors Consumption (2018-2029) & (K Units)
Figure 22. India PDE 4 Inhibitors Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of PDE 4 Inhibitors by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for PDE 4 Inhibitors Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for PDE 4 Inhibitors Markets in 2022
Figure 26. United States VS China: PDE 4 Inhibitors Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: PDE 4 Inhibitors Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: PDE 4 Inhibitors Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers PDE 4 Inhibitors Production Market Share 2022
Figure 30. China Based Manufacturers PDE 4 Inhibitors Production Market Share 2022
Figure 31. Rest of World Based Manufacturers PDE 4 Inhibitors Production Market Share 2022
Figure 32. World PDE 4 Inhibitors Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World PDE 4 Inhibitors Production Value Market Share by Type in 2022
Figure 34. Rolipram
Figure 35. Tetomilast
Figure 36. Cilomilast
Figure 37. Criborole
Figure 38. Apremilast
Figure 39. Roflumilast
Figure 40. Others
Figure 41. World PDE 4 Inhibitors Production Market Share by Type (2018-2029)
Figure 42. World PDE 4 Inhibitors Production Value Market Share by Type (2018-2029)
Figure 43. World PDE 4 Inhibitors Average Price by Type (2018-2029) & (US$/Unit)
Figure 44. World PDE 4 Inhibitors Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 45. World PDE 4 Inhibitors Production Value Market Share by Application in 2022
Figure 46. Psoriasis
Figure 47. Chronic Obstructive Pulmonary Disease (COPD)
Figure 48. Asthma
Figure 49. Ankylosing Spondylitis (AS)
Figure 50. Inflammatory Bowel Disease (IBD)
Figure 51. Atopic Dermatitis
Figure 52. Rheumatoid Arthritis (RA)
Figure 53. Systemic Lupus Erythematosus (SLE)
Figure 54. Others
Figure 55. World PDE 4 Inhibitors Production Market Share by Application (2018-2029)
Figure 56. World PDE 4 Inhibitors Production Value Market Share by Application (2018-2029)
Figure 57. World PDE 4 Inhibitors Average Price by Application (2018-2029) & (US$/Unit)
Figure 58. PDE 4 Inhibitors Industry Chain
Figure 59. PDE 4 Inhibitors Procurement Model
Figure 60. PDE 4 Inhibitors Sales Model
Figure 61. PDE 4 Inhibitors Sales Channels, Direct Sales, and Distribution
Figure 62. Methodology
Figure 63. Research Process and Data Source
Figure 1. PDE 4 Inhibitors Picture
Figure 2. World PDE 4 Inhibitors Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World PDE 4 Inhibitors Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World PDE 4 Inhibitors Production (2018-2029) & (K Units)
Figure 5. World PDE 4 Inhibitors Average Price (2018-2029) & (US$/Unit)
Figure 6. World PDE 4 Inhibitors Production Value Market Share by Region (2018-2029)
Figure 7. World PDE 4 Inhibitors Production Market Share by Region (2018-2029)
Figure 8. North America PDE 4 Inhibitors Production (2018-2029) & (K Units)
Figure 9. Europe PDE 4 Inhibitors Production (2018-2029) & (K Units)
Figure 10. China PDE 4 Inhibitors Production (2018-2029) & (K Units)
Figure 11. Japan PDE 4 Inhibitors Production (2018-2029) & (K Units)
Figure 12. PDE 4 Inhibitors Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World PDE 4 Inhibitors Consumption (2018-2029) & (K Units)
Figure 15. World PDE 4 Inhibitors Consumption Market Share by Region (2018-2029)
Figure 16. United States PDE 4 Inhibitors Consumption (2018-2029) & (K Units)
Figure 17. China PDE 4 Inhibitors Consumption (2018-2029) & (K Units)
Figure 18. Europe PDE 4 Inhibitors Consumption (2018-2029) & (K Units)
Figure 19. Japan PDE 4 Inhibitors Consumption (2018-2029) & (K Units)
Figure 20. South Korea PDE 4 Inhibitors Consumption (2018-2029) & (K Units)
Figure 21. ASEAN PDE 4 Inhibitors Consumption (2018-2029) & (K Units)
Figure 22. India PDE 4 Inhibitors Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of PDE 4 Inhibitors by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for PDE 4 Inhibitors Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for PDE 4 Inhibitors Markets in 2022
Figure 26. United States VS China: PDE 4 Inhibitors Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: PDE 4 Inhibitors Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: PDE 4 Inhibitors Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers PDE 4 Inhibitors Production Market Share 2022
Figure 30. China Based Manufacturers PDE 4 Inhibitors Production Market Share 2022
Figure 31. Rest of World Based Manufacturers PDE 4 Inhibitors Production Market Share 2022
Figure 32. World PDE 4 Inhibitors Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World PDE 4 Inhibitors Production Value Market Share by Type in 2022
Figure 34. Rolipram
Figure 35. Tetomilast
Figure 36. Cilomilast
Figure 37. Criborole
Figure 38. Apremilast
Figure 39. Roflumilast
Figure 40. Others
Figure 41. World PDE 4 Inhibitors Production Market Share by Type (2018-2029)
Figure 42. World PDE 4 Inhibitors Production Value Market Share by Type (2018-2029)
Figure 43. World PDE 4 Inhibitors Average Price by Type (2018-2029) & (US$/Unit)
Figure 44. World PDE 4 Inhibitors Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 45. World PDE 4 Inhibitors Production Value Market Share by Application in 2022
Figure 46. Psoriasis
Figure 47. Chronic Obstructive Pulmonary Disease (COPD)
Figure 48. Asthma
Figure 49. Ankylosing Spondylitis (AS)
Figure 50. Inflammatory Bowel Disease (IBD)
Figure 51. Atopic Dermatitis
Figure 52. Rheumatoid Arthritis (RA)
Figure 53. Systemic Lupus Erythematosus (SLE)
Figure 54. Others
Figure 55. World PDE 4 Inhibitors Production Market Share by Application (2018-2029)
Figure 56. World PDE 4 Inhibitors Production Value Market Share by Application (2018-2029)
Figure 57. World PDE 4 Inhibitors Average Price by Application (2018-2029) & (US$/Unit)
Figure 58. PDE 4 Inhibitors Industry Chain
Figure 59. PDE 4 Inhibitors Procurement Model
Figure 60. PDE 4 Inhibitors Sales Model
Figure 61. PDE 4 Inhibitors Sales Channels, Direct Sales, and Distribution
Figure 62. Methodology
Figure 63. Research Process and Data Source
